167 related articles for article (PubMed ID: 37270458)
21. The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model.
Zhao Y; Ruan X; Wang H; Li X; Gu M; Wang L; Li Y; Seeger H; Mueck AO
Maturitas; 2017 Aug; 102():26-33. PubMed ID: 28610679
[TBL] [Abstract][Full Text] [Related]
22. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
23. The estrogenic activity of synthetic progestins used in oral contraceptives.
Jordan VC; Jeng MH; Catherino WH; Parker CJ
Cancer; 1993 Feb; 71(4 Suppl):1501-5. PubMed ID: 8431886
[TBL] [Abstract][Full Text] [Related]
24. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
25. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
26. Progestin receptors in human uterine cytosol.
Kasid A; Laumas KR
Mol Cell Endocrinol; 1980 Aug; 19(2):131-42. PubMed ID: 7409303
[TBL] [Abstract][Full Text] [Related]
27. Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
Liang Y; Benakanakere I; Besch-Williford C; Hyder RS; Ellersieck MR; Hyder SM
Menopause; 2010; 17(5):1040-7. PubMed ID: 20461021
[TBL] [Abstract][Full Text] [Related]
28. The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
Carroll CE; Liang Y; Benakanakere I; Besch-Williford C; Hyder SM
Int J Oncol; 2013 Jan; 42(1):179-87. PubMed ID: 23123638
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
Weber-Diehl F; Lehnert J; Lachnit U
Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
[TBL] [Abstract][Full Text] [Related]
30. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.
Weisberg E; Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Nash HA
Contraception; 1999 May; 59(5):311-8. PubMed ID: 10494485
[TBL] [Abstract][Full Text] [Related]
31. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
32. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
[TBL] [Abstract][Full Text] [Related]
33. [Oral contraception and its beneficial gynecological effects].
Belaisch J; Hommais-loufrani B
Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
[TBL] [Abstract][Full Text] [Related]
34. AEG-1 Contributes to Metastasis in Hypoxia-Related Ovarian Cancer by Modulating the HIF-1alpha/NF-kappaB/VEGF Pathway.
Yu X; Wang Y; Qiu H; Song H; Feng D; Jiang Y; Deng S; Meng H; Geng J
Biomed Res Int; 2018; 2018():3145689. PubMed ID: 29770329
[TBL] [Abstract][Full Text] [Related]
35. Hormonal effects of the 300 microgram norethisterone (NET) minipill. 2. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration.
Landgren BM; Balogh A; Shin MW; Lindberg M; Diczfalusy E
Contraception; 1979 Dec; 20(6):585-605. PubMed ID: 535366
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral contraceptive progestins on serum copper concentration.
Berg G; Kohlmeier L; Brenner H
Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
[TBL] [Abstract][Full Text] [Related]
37. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
38. Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjects.
Landgren BM; Lager S; Diczfalusy E
Contraception; 1981 Mar; 23(3):269-99. PubMed ID: 6786830
[TBL] [Abstract][Full Text] [Related]
39. The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Eur J Gynaecol Oncol; 2001; 22(5):331-5. PubMed ID: 11766732
[TBL] [Abstract][Full Text] [Related]
40. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
Seeger H; Wallwiener D; Mueck AO
Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
